Day One Biopharmaceuticals Holding Co LLC Intellectual Property Contracts & Agreements
5 Contracts & Agreements
- License Agreements (5 contracts)
- Exclusive License Agreement by and between MabCare Therapeutics and Day One Biopharmaceuticals, Inc. dated June 17, 2024 (Filed With SEC on August 2, 2024)
- Amendment No. 1 to the License Agreement for RAF, dated March 4, 2024, by and between Day One Biopharmaceuticals, Inc. and Sunesis Pharmaceuticals, Inc (Filed With SEC on March 7, 2024)
- License Agreement, dated February 10, 2021, by and between Merck KGaA, Darmstadt, Germany and Day One Biopharmaceuticals, Inc (Filed With SEC on May 4, 2021)
- License Agreement for RAF, effective as of December 16, 2019, by and between Sunesis Pharmaceuticals, Inc. and DOT Therapeutics-1, Inc (Filed With SEC on May 4, 2021)
- Asset Transfer and License Agreement, effective as of December 16, 2019, by and between DOT Therapeutics-1, Inc. and Millennium Pharmaceuticals, Inc (Filed With SEC on May 4, 2021)
